- 新聞
- 活動
- 文獻發表
- 外部來源
-
2022Jun
16
Interview with HCmed's Manufacturing Department Director, Chester LinAs the Director of the Manufacturing Department at HCmed Innovations, Chester Lin leads the department on plant design, management and production, aiming to improve production and efficiency whilst reducing waste and costs .
-
2022May
19
Interview with HCmed's Regulatory Affairs Manager, Michelle PiehMichelle Pieh shares her experience leading the regulatory affairs and quality assurance teams at HCmed.
-
2022May
04
Pulmogine Is Included in the Australian Register of Therapeutic Goods (ARTG)Pulmogine, a vibrating mesh nebulizer developed by HCmed, has been included in the Australian Register of Therapeutic Goods (ARTG) since April 2022.
-
2022Mar
31
Interview with HCmed's BD Director, Connie ChenDirector of Business Department at HCmed Innovations, Connie Chen this month shares her experience and thoughts working in the biomedical industry.
-
2022Feb
23
Interview with HCmed's Project Manager, Ellie ChenAs the head of the Project Management Department, Ellie Chen this week shares her experience working at HCmed Innovations Co., Ltd.
-
2022Jan
10
Interview with HCmed's BD Manager & Scientist, Hernan Cuevas BrunHernan Cuevas Brun, Business Development Manager and Aerosol Drug Delivery Scientist at HCmed Innovations, this week shares his experience working in the industry of developing nebulizers and combination products.
-
2021Nov
19
Interview with HCmed's R&D Director, Yuan-Ming HsuThis week Yuan-Ming Hsu, Director of the R&D Department at HCmed Innovations, shares his thoughts and experience working in the medical device industry.
-
2021Oct
18
Interview with HCmed's COO, Leon TsaiHCmed's COO, Leon Tsai, shares his experience in the development of mesh nebulizer and his motivation to improve these devices to provide more effective solutions for inhalation therapy.
-
2021Aug
18
HCmed and Cellics Announce Collaboration on Nebulized Nanosponges for the Treatment of Bacterial Infections and Inflammatory DiseasesHCmed Innovations Co., Ltd. (HCmed) and Cellics Therapeutics, Inc. (Cellics) have initiated a collaboration, introducing inhalation therapy for the delivery of nanospages.